Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation

NCT04575077 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT04575077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04575077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Unknown status
Start date
September 16, 2020
Completion date
August 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease